John Henry Elder
#161,620
Most Influential Person Now
John Henry Elder's AcademicInfluence.com Rankings
John Henry Elderbiology Degrees
Biology
#12841
World Rank
#16344
Historical Rank
Biochemistry
#2219
World Rank
#2365
Historical Rank

Download Badge
Biology
John Henry Elder's Degrees
- PhD Biochemistry University of California, Berkeley
- Bachelors Chemistry Stanford University
Why Is John Henry Elder Influential?
(Suggest an Edit or Addition)John Henry Elder's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Improved technique utilizing nonfat dry milk for analysis of proteins and nucleic acids transferred to nitrocellulose (1984) (1657)
- Identification of alpha-dystroglycan as a receptor for lymphocytic choriomeningitis virus and Lassa fever virus. (1998) (672)
- Radioiodination of proteins in single polyacrylamide gel slices. Tryptic peptide analysis of all the major members of complex multicomponent systems using microgram quantities of total protein. (1977) (566)
- endo-beta-N-acetylglucosaminidase F: endoglycosidase from Flavobacterium meningosepticum that cleaves both high-mannose and complex glycoproteins. (1982) (487)
- Inhibitors of HIV-1 protease by using in situ click chemistry. (2006) (447)
- Demonstration of peptide:N-glycosidase F activity in endo-beta-N-acetylglucosaminidase F preparations. (1984) (440)
- Nucleotide sequence and genomic organization of feline immunodeficiency virus. (1989) (400)
- Biochemical evidence that MCF murine leukemia viruses are envelope (env) gene recombinants. (1977) (333)
- Comparison of two host cell range variants of feline immunodeficiency virus (1990) (253)
- von Willebrand factor. A reduced and alkylated 52/48-kDa fragment beginning at amino acid residue 449 contains the domain interacting with platelet glycoprotein Ib. (1986) (249)
- 1,2,3‐Triazole as a Peptide Surrogate in the Rapid Synthesis of HIV‐1 Protease Inhibitors (2005) (240)
- Expression of leukemogenic recombinant viruses associated with a recessive gene in HRS/J mice (1980) (228)
- Polymorphism of the major envelope glycoprotein (gp70) of murine C-type viruses: virion associated and differentiation antigens encoded by a multi-gene family (1977) (224)
- A copper(I)-catalyzed 1,2,3-triazole azide-alkyne click compound is a potent inhibitor of a multidrug-resistant HIV-1 protease variant. (2008) (213)
- Minimum Requirements for Efficient Transduction of Dividing and Nondividing Cells by Feline Immunodeficiency Virus Vectors (1999) (201)
- Multiple Antiviral Activities of Cyanovirin-N: Blocking of Human Immunodeficiency Virus Type 1 gp120 Interaction with CD4 and Coreceptor and Inhibition of Diverse Enveloped Viruses (2000) (190)
- Rapid discovery and structure-activity profiling of novel inhibitors of human immunodeficiency virus type 1 protease enabled by the copper(I)-catalyzed synthesis of 1,2,3-triazoles and their further functionalization. (2006) (186)
- The T3 complex on human T lymphocytes involves four structurally distinct glycoproteins. (1983) (167)
- Carbohydrate dramatically influences immune reactivity of antisera to viral glycoprotein antigens. (1984) (162)
- Distinct subsets of retroviruses encode dUTPase (1992) (159)
- Robust expression of a bioactive mammalian protein in Chlamydomonas chloroplast. (2007) (137)
- Neurological abnormalities associated with feline immunodeficiency virus infection. (1994) (133)
- Feline immunodeficiency virus infects both CD4+ and CD8+ T lymphocytes (1991) (128)
- Rapid Diversity‐Oriented Synthesis in Microtiter Plates for In Situ Screening of HIV Protease Inhibitors (2003) (126)
- Identification of the Rev transactivation and Rev-responsive elements of feline immunodeficiency virus (1992) (125)
- Feline immunodeficiency virus targets activated CD4+ T cells by using CD134 as a binding receptor. (2004) (114)
- Nucleotide Sequence of the Envelope Gene of Gardner-Arnstein Feline Leukemia Virus B Reveals Unique Sequence Homologies with a Murine Mink Cell Focus-Forming Virus (1983) (112)
- Increased mutation frequency of feline immunodeficiency virus lacking functional deoxyuridine-triphosphatase. (1995) (112)
- Regulation of gene expression directed by the long terminal repeat of the feline immunodeficiency virus. (1992) (107)
- Feline immunodeficiency virus (FIV) as a model for study of lentivirus infections: parallels with HIV. (2010) (104)
- Identification of proteolytic processing sites within the Gag and Pol polyproteins of feline immunodeficiency virus (1993) (97)
- Binding of Recombinant Feline Immunodeficiency Virus Surface Glycoprotein to Feline Cells: Role of CXCR4, Cell-Surface Heparans, and an Unidentified Non-CXCR4 Receptor (2001) (93)
- Conformational flexibility in the flap domains of ligand-free HIV protease. (2007) (91)
- Human Immunodeficiency Virus Envelope (gp120) Binding to DC-SIGN and Primary Dendritic Cells Is Carbohydrate Dependent but Does Not Involve 2G12 or Cyanovirin Binding Sites: Implications for Structural Analyses of gp120-DC-SIGN Binding (2002) (88)
- Protein structure of lymphocytic choriomeningitis virus: identification of the virus structural and cell associated polypeptides. (1978) (88)
- A Highly Conserved Arginine in gp120 Governs HIV-1 Binding to Both Syndecans and CCR5 via Sulfated Motifs* (2005) (83)
- Identification of efficiently cleaved substrates for HIV-1 protease using a phage display library and use in inhibitor development. (2000) (82)
- Selectivity in the Inhibition of HIV and FIV Protease: Inhibitory and Mechanistic Studies of Pyrrolidine-Containing .alpha.-Keto Amide and Hydroxyethylamine Core Structures (1995) (81)
- Carbohydrate moiety of von Willebrand factor is not necessary for maintaining multimeric structure and ristocetin cofactor activity but protects from proteolytic degradation. (1984) (77)
- Neurologic dysfunctions caused by a molecular clone of feline immunodeficiency virus, FIV-PPR. (1996) (76)
- Structural markers on core protein p30 of murine leukemia virus: functional correlation with Fv-1 tropism. (1978) (75)
- Analysis of the S3 and S3' subsite specificities of feline immunodeficiency virus (FIV) protease: development of a broad-based protease inhibitor efficacious against FIV, SIV, and HIV in vitro and ex vivo. (1998) (75)
- Blocking of feline immunodeficiency virus infection by a monoclonal antibody to CD9 is via inhibition of virus release rather than interference with receptor binding (1997) (70)
- Demonstration that orf2 Encodes the Feline Immunodeficiency Virus Transactivating (Tat) Protein and Characterization of a Unique Gene Product with Partial Rev Activity (1999) (70)
- Feline immunodeficiency virus is a lentivirus associated with an AIDS‐like disease in cats (1989) (68)
- Sleep patterns are disturbed in cats infected with feline immunodeficiency virus. (1994) (66)
- Molecular cloning and characterization of deoxyuridine triphosphatase from feline immunodeficiency virus (FIV). (1993) (65)
- Crystal structure of dUTP pyrophosphatase from feline immunodeficiency virus (1996) (65)
- The role of retroviral dUTPases in replication and virulence. (2001) (62)
- Structural mapping of CD134 residues critical for interaction with feline immunodeficiency virus (2005) (62)
- Workshop Summary: Lessons from the Cat: Feline Immunodeficiency Virus as a Tool to Develop Intervention Strategies against Human Immunodeficiency Virus Type 1 (1998) (62)
- Identification of retroviral gp70 and anti-gp70 antibodies involved in circulating immune complexes in NZB X NZW mice (1981) (59)
- Influence of ORF2 on host cell tropism of feline immunodeficiency virus. (1996) (56)
- Development of a New Type of Protease Inhibitors, Efficacious against FIV and HIV Variants (1999) (54)
- Crystal structures of the inactive D30N mutant of feline immunodeficiency virus protease complexed with a substrate and an inhibitor. (1997) (54)
- Biological, immunological, and biochemical evidence that HIX virus is a recombinant between Moloney leukemia virus and a murine xenotropic C type virus. (1978) (53)
- Characterization of a Highly Pathogenic Molecular Clone of Feline Immunodeficiency Virus Clade C (2004) (53)
- A quick diversity-oriented amide-forming reaction to optimize P-subsite residues of HIV protease inhibitors. (2002) (52)
- Localization of neutralizing regions of the envelope gene of feline leukemia virus by using anti-synthetic peptide antibodies (1987) (52)
- Molecular mechanisms of FIV infection. (2008) (51)
- Expanded Host Cell Tropism and Cytopathic Properties of Feline Immunodeficiency Virus Strain PPR Subsequent to Passage through Interleukin-2-Independent T Cells (2000) (51)
- Differential expression of two distinct xenotropic viruses in NZB mice. (1980) (48)
- Synthesis in vitro of intrinsic membrane proteins by free, membrane-bound, and Golgi apparatus-associated polyribosomes from rat liver. (1976) (48)
- Infection of cats with molecularly cloned and biological isolates of the feline immunodeficiency virus. (1994) (48)
- Endoglycosidases from Flavobacterium meningosepticum application to biological problems. (1989) (47)
- Factors That Increase the Effective Concentration of CXCR4 Dictate Feline Immunodeficiency Virus Tropism and Kinetics of Replication (2004) (47)
- Sequential CD134-CXCR4 Interactions in Feline Immunodeficiency Virus (FIV): Soluble CD134 Activates FIV Env for CXCR4-Dependent Entry and Reveals a Cryptic Neutralization Epitope (2006) (46)
- Lessons from the cat: feline immunodeficiency virus as a tool to develop intervention strategies against human immunodeficiency virus type 1. (1998) (44)
- Feline immunodeficiency virus as a model for study of lentivirus infection of the central nervous system. (1995) (43)
- Human Immunodeficiency Virus Type 1 and Influenza Virus Exit via Different Membrane Microdomains (2007) (43)
- Evaluation of feline immunodeficiency virus and feline leukemia virus transmembrane peptides for serological diagnosis (1992) (42)
- Specific Interaction of Feline Immunodeficiency Virus Surface Glycoprotein with Human DC-SIGN (2004) (41)
- Defining HIV-1 protease substrate selectivity. (2002) (40)
- Cis- and trans-regulation of feline immunodeficiency virus: identification of functional binding sites in the long terminal repeat. (1994) (40)
- Antibody directed to determinants of a Moloney virus derived MCF GP70 recognizes a thymic differentiation antigen (1983) (39)
- Feline Immunodeficiency Virus OrfA Is Distinct from Other Lentivirus Transactivators (2002) (39)
- FIV infection of IL-2-dependent and -independent feline lymphocyte lines: Host cells range distinctions and specific cytokine upregulation (1998) (38)
- Molecular properties of feline immunodeficiency virus (FIV). (1993) (38)
- Structures of feline immunodeficiency virus dUTP pyrophosphatase and its nucleotide complexes in three crystal forms. (2000) (37)
- Crystallographic Fragment‐Based Drug Discovery: Use of a Brominated Fragment Library Targeting HIV Protease (2014) (36)
- Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120 (2006) (36)
- Feline immunodeficiency virus as a model for development of molecular approaches to intervention strategies against lentivirus infections. (1995) (36)
- Neurotoxic effects of feline immunodeficiency virus, FIV-PPR. (1998) (36)
- Crystal structure of an FIV/HIV chimeric protease complexed with the broad-based inhibitor, TL-3 (2007) (36)
- Induction of high serum levels of retroviral env gene products (gp70) in mice by bacterial lipopolysaccharide. (1981) (35)
- Structural studies of FIV and HIV‐1 proteases complexed with an efficient inhibitor of FIV protease (2000) (34)
- Small molecule regulation of protein conformation by binding in the Flap of HIV protease. (2013) (33)
- Pathogenesis of the slow disease of the central nervous system associated with wild mouse virus. III. Role of input virus and MCF recombinants in disease. (1983) (33)
- Intraventricular administration of a FIV-envelope protein induces sleep architecture changes in rats (1994) (32)
- Immunoregulatory properties of human esophageal tumor extract. (1979) (32)
- Feline Immunodeficiency Virus Vif Localizes to the Nucleus (2000) (32)
- Viral Evolution in Response to the Broad-Based Retroviral Protease Inhibitor TL-3 (2001) (31)
- Molecular dissection of Rauscher virus gp70 by using monoclonal antibodies: localization of acquired sequences of related envelope gene recombinants. (1980) (31)
- Molecular Basis for the Relative Substrate Specificity of Human Immunodeficiency Virus Type 1 and Feline Immunodeficiency Virus Proteases (2001) (31)
- HIV- and FIV-Derived gp120 Alter Spatial Memory, LTP, and Sleep in Rats (2000) (31)
- Alteration of Substrate and Inhibitor Specificity of Feline Immunodeficiency Virus Protease (2000) (31)
- Comparative properties of feline immunodeficiency virus (FIV) and human immunodeficiency virus type 1 (HIV-1) proteinases prepared by total chemical synthesis. (1996) (30)
- Carbohydrate side chains of Rauscher leukemia virus envelope glycoproteins are not required to elicit a neutralizing antibody response (1986) (28)
- Characterization of a membrane surface glycoprotein associated with T-cell activation. (1985) (28)
- Structural analysis of the major envelope glycoprotein (gp70) of the amphotropic and ecotropic type C viruses of wild mice. (1978) (27)
- Replication Properties of Clade A/C Chimeric Feline Immunodeficiency Viruses and Evaluation of Infection Kinetics in the Domestic Cat (2008) (26)
- A simple and rapid procedure for the purification of plasmid DNA using reverse-phase C18 silica beads. (1983) (25)
- Protection against feline leukemia virus infection by use of an inactivated virus vaccine. (1991) (25)
- Is resistance futile? (2003) (24)
- Derivatives of 4‐amino‐3,6‐disulfonato‐1, 8‐naphthalimide inhibit reverse transcriptase and suppress human and feline immunodeficiency virus expression in cultured cells (1993) (24)
- Type 1 diabetes pathogenesis is modulated by spontaneous autoimmune responses to endogenous retrovirus antigens in NOD mice (2017) (24)
- Identification of the protein product of the c-mos proto-oncogene in mouse testes. (1988) (23)
- Characterization of endogenous and recombinant proviral elements of a highly tumorigenic AKR cell line (1991) (23)
- Multigene family of endogenous retroviruses: recombinant origin of diversity. (1978) (22)
- Structural insights into the mechanisms of drug resistance in HIV-1 protease NL4-3. (2006) (22)
- Structural Basis for Distinctions between Substrate and Inhibitor Specificities for Feline Immunodeficiency Virus and Human Immunodeficiency Virus Proteases (2003) (22)
- Molecular analysis of the feline immunodeficiency virus protease: generation of a novel form of the protease by autoproteolysis and construction of cleavage-resistant proteases (1997) (22)
- Detection of a recombinant murine leukemia virus-related glycoprotein on virus-negative thymoma cells. (1981) (22)
- Identification of broad-based HIV-1 protease inhibitors from combinatorial libraries. (2010) (21)
- Conserved primary sequences of the DNA terminal proteins of five different human adenovirus groups. (1979) (21)
- Resolution and Prevention of Feline Immunodeficiency Virus-Induced Neurological Deficits by Treatment with the Protease Inhibitor TL-3 (2004) (21)
- Feline immunodeficiency virus OrfA alters gene expression of splicing factors and proteasome-ubiquitination proteins. (2008) (21)
- Mapping of the CXCR4 Binding Site within Variable Region 3 of the Feline Immunodeficiency Virus Surface Glycoprotein (2008) (21)
- Natural feline leukemia virus variant escapes neutralization by a monoclonal antibody via an amino acid change outside the antibody-binding epitope (1987) (21)
- B-MuX: a unique murine C-type virus containing the "env" gene of xenotropic viruses and the "gag" gene of the ecotropic virus. (1978) (20)
- Accessory Genes Confer a High Replication Rate to Virulent Feline Immunodeficiency Virus (2013) (20)
- Fine Definition of the CXCR4-Binding Region on the V3 Loop of Feline Immunodeficiency Virus Surface Glycoprotein (2010) (20)
- Cortical neuronal cytoskeletal changes associated with FIV infection. (1997) (20)
- Assessment of FIV-C infection of cats as a function of treatment with the protease inhibitor, TL-3 (2004) (20)
- Altered Gag Polyprotein Cleavage Specificity of Feline Immunodeficiency Virus/Human Immunodeficiency Virus Mutant Proteases as Demonstrated in a Cell-Based Expression System (2006) (20)
- Nearest-neighbor interactions of the major RNA tumor virus glycoprotein on murine cell surfaces. (1978) (20)
- Association of elevated serum glycoprotein gp70 with increased gp70 immune complex formation and accelerated lupus nephritis in autoimmune male BXSB mice. (1984) (19)
- Strain-specific viral distribution and neuropathology of feline immunodeficiency virus. (2011) (19)
- OrfA Downregulates Feline Immunodeficiency Virus Primary Receptor CD134 on the Host Cell Surface and Is Important in Viral Infection (2010) (19)
- Applications of the FIV Model to Study HIV Pathogenesis (2018) (19)
- Structural analysis of Rauscher virus Gp70 using monoclonal antibodies: sites of antigenicity and P15(E) linkage. (1982) (18)
- Improved health and survival of FIV-infected cats is associated with the presence of autoantibodies to the primary receptor, CD134 (2009) (18)
- Chemical determination of the m1 Moloney sarcoma virus pP60gag gene order: evidence for unique peptides in the carboxy terminus of the polyprotein. (1978) (18)
- In vitro construction of a B-tropic virus by recombination: B-tropism is a cryptic phenotype of xenotropic murine retroviruses. (1980) (18)
- Structural characterization of the human T cell surface antigen (p67) isolated from normal and neoplastic lymphocytes. (1982) (17)
- Dissecting the molecular anatomy of the nervous system: Analysis of RNA and protein expression in whole body sections of laboratory animals (1986) (17)
- Design and synthesis of broad-based mono- and bi- cyclic inhibitors of FIV and HIV proteases. (2003) (16)
- Inhibition of the ERK pathway prevents HIVgp120-induced REM sleep increase (2001) (16)
- Feline immunodeficiency virus (FIV)-specific cytotoxic T lymphocytes from chronically infected cats are induced in vitro by retroviral vector-transduced feline T cells expressing the FIV capsid protein. (1995) (15)
- Stimulation of murine lymphocytes by Rauscher leukemia virus in vitro. (1980) (14)
- Nicotine prevents HIVgp120-caused electrophysiological and motor disturbances in rats (2006) (14)
- Influence of Soils on Bacterial Contamination of a Watershed from Septic Sources 1 (1975) (14)
- Structure-activity studies of FIV and HIV protease inhibitors containing allophenylnorstatine. (2001) (14)
- Identification of Amino Acid Residues Important for Heparan Sulfate Proteoglycan Interaction within Variable Region 3 of the Feline Immunodeficiency Virus Surface Glycoprotein (2011) (14)
- HIV‐derived protein gp120 suppresses P3 potential in rats: potential implications in HIV‐associated dementia (2000) (13)
- COMPARATIVE STUDIES ON THE SMALL BACILLUS BACTERIOPHAGES (1986) (13)
- Specificities of NZB anti-H-2d CML reactions: role of Qa-1 and retroviral gp70 antigens. (1981) (13)
- Feline immunodeficiency virus envelope protein (FIVgp120) causes electrophysiological alterations in rats (1999) (13)
- A continuous fluorometric assay for the feline immunodeficiency virus protease. (1997) (12)
- Epoxide opening in water and screening in situ for rapid discovery of enzyme inhibitors in microtiter plates. (2006) (12)
- Design, synthesis, and biological evaluation of HIV/FIV protease inhibitors incorporating a conformationally constrained macrocycle with a small P3' residue. (2001) (11)
- Retroviral vector-transduced cells expressing the core polyprotein induce feline immunodeficiency virus-specific cytotoxic T-lymphocytes from infected cats. (1995) (11)
- Pathogenicity and Rapid Growth Kinetics of Feline Immunodeficiency Virus Are Linked to 3′ Elements (2011) (11)
- Analysis of the S 3 and S 3 * subsite specificities of feline immunodeficiency virus ( FIV ) protease : Development of a broad-based protease inhibitor efficacious against FIV , SIV , and HIV in vitro and ex vivo (1998) (11)
- Domestic cat microsphere immunoassays: detection of antibodies during feline immunodeficiency virus infection. (2013) (11)
- A microanalytical protein assay using laser densitometry. (1984) (11)
- Isolation of two novel envelope recombinant leukemogenic viruses from moloney leukemia virus stocks (1981) (10)
- HIV induces synaptic hyperexcitation via cGMP-dependent protein kinase II activation in the FIV infection model (2018) (10)
- Engineering Properties of Soils as Related to Mineralogy and Particle-Size Distribution1 (1984) (9)
- FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge (2018) (9)
- Structural basis for drug and substrate specificity exhibited by FIV encoding a chimeric FIV/HIV protease. (2011) (9)
- Prolonged waking reduces human immunodeficiency virus glycoprotein 120- or tumor necrosis factor alpha-induced apoptosis in the cerebral cortex of rats (2004) (7)
- Generation of Infectious Feline Immunodeficiency Virus (FIV) Encoding FIV/Human Immunodeficiency Virus Chimeric Protease (2010) (7)
- Effect of tRNA on the Maturation of HIV-1 Reverse Transcriptase. (2018) (7)
- On the Role of Recombinant Retroviruses in Murine Leukemia (1984) (7)
- Early detection of neuropathophysiology using diffusion-weighted magnetic resonance imaging in asymptomatic cats with feline immunodeficiency viral infection (2011) (7)
- A single-stranded nucleic acid binding sequence common to the heterogeneous nuclear ribonucleoparticle protein A1 and murine recombinant virus gp70. (1990) (6)
- An unusual retrovirus-like sequence identified in human DNA. (1990) (6)
- Mapping of Receptor Binding Interactions with the FIV surface Glycoprotein (SU); Implications Regarding Immune surveillance and cellular Targets of Infection. (2012) (6)
- Selective Interaction of Heparin with the Variable Region 3 within Surface Glycoprotein of Laboratory-Adapted Feline Immunodeficiency Virus (2014) (6)
- Structural diversity among retroviral gene products: a molecular approach to the study of biological function through structural variability. (1981) (5)
- of the Feline Immunodeficiency Virus Surface Glycoprotein 2 3 (2008) (5)
- Calcium uptake by sarcoplasmic reticulum of rat muscle: inhibition by DDT. (1979) (5)
- Breaking the shackles of the genetic code: engineering retroviral proteases through total chemical synthesis. (1995) (5)
- Rapid Multiplexed Immunoassay for Detection of Antibodies to Kaposi’s Sarcoma-Associated Herpesvirus (2016) (5)
- Immunopathologic Effects of Prednisolone and Cyclosporine A on Feline Immunodeficiency Virus Replication and Persistence (2019) (5)
- Toxicity of 2,4-D and Picloram to Fresh Water Algae (1970) (4)
- The Toxicity of 2,4-D and Picloram Herbicides to Fish (1970) (4)
- Scale Calcification in a Chrysophycean Alga: A Test System for the Effects of DDT on Biological Calcification (1971) (4)
- [Cat retroviruses and human retroviruses: elements of comparison]. (1989) (2)
- A unique variant of lymphocytic choriomeningitis virus that induces pheromone binding protein MUP: Critical role for CTL (2019) (2)
- Modification of immuno blotting technique for detection and quantitation of infectious virus in cell mono layers (1984) (2)
- Soil Survey of Maury County, Tennessee (1959) (2)
- endoP . fN-Acetylglucosaminidase F : Endoglycosidase from ' Flavobacterium meningosepticum-that cleaves both high-mannose and complex ' glycoproteins ( Rauscher leukemia virus gp 70 / glycan structure / deglycosylation / N-linked glycan ) (1)
- Unidentified Non-CXCR 4 Receptor CXCR 4 , Cell-Surface Heparans , and an Glycoprotein to Feline Cells : Role of Immunodeficiency Virus Surface Binding of Recombinant Feline (2001) (1)
- Humoral Antibody Responses to HIV Viral Proteins and to CD4 Among HIV Controllers, Rapid and Typical Progressors in an HIV-Positive Patient Cohort (2016) (1)
- Expanded Host Cell Tropism and Cytopathic Properties of Feline Immunodeficiency Virus Strain PPR Subsequent to Passage through Interleukin2Independent Interleukin2Independent Interleukin2Independent 2Independent 2Independent T Cells (2000) (1)
- Crystal structure of FIV dUTP pyrophosphatase (1996) (1)
- Inhibition by DDT of Calcium Accumulation in Isolated Cell Fractions from Rat Muscle (1973) (1)
- Professional field day: A stimulus to undergraduate programs in plant science curricula (1974) (1)
- mAbs as Probes of Protein Structure: Molecular Diversity among the Envelope Glycoproteins (Gp70S) of the Murine Retroviruses (2019) (1)
- Correction (2022) (0)
- The structure of FIV 12S protease in complex with TL-3 (2007) (0)
- Structure of HIV Protease NL4-3 in an Unliganded State (2007) (0)
- STRUCTURAL STUDIES OF HIV AND FIV PROTEASES COMPLEXED WITH AN EFFICIENT INHIBITOR OF FIV PR (1998) (0)
- Fv-1 locus of the mouse. Abstr. (1978) (0)
- Design, Synthesis, and Biological Evaluation of HIV/FIV Protease Inhibitors (I) Incorporating a Conformationally Constrained Macrocycle with a Small P3′ Residue. (2001) (0)
- FIV DUTP PYROPHOSPHATASE (1997) (0)
- Mapping of the CXCR4 Binding Site within Variable Region 3 of the Feline Immunodeficiency Virus Surface Glycoprotein (cid:1) (2008) (0)
- Identification of Amino Acid Residues Important for Heparan Sulfate 1 Proteoglycan (HSPG) Interaction within Variable Region 3 of the Feline 2 (2011) (0)
- Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2G12 as probed by Fc-tagged gp120 (2007) (0)
- Structure of the D30N active site mutant of FIV proteinase complexed with a statine-based inhibitor (1997) (0)
- Toxicity of 2,4-D and picloram to fresh and salt water algae. (1970) (0)
- Lessons from the cat: use of feline immunodeficiency virus (FIV) as a means to develop intervention strategies effective against human immunodeficiency virus type 1 (HIV-1) (1998) (0)
- HIV-1 Protease NL4-3 in complex with inhibitor, TL-3 (2006) (0)
- Comparison ofTwoHostCellRangeVariants ofFeline Immunodeficiency Virus (1990) (0)
- HIV-1 Protease NL4-3 1X mutant (2006) (0)
- HIV-1 Protease NL4-3 6X mutant (2006) (0)
- interference with receptor binding. via inhibition of virus release rather than infection by a monoclonal antibody to CD9 is Blocking of feline immunodeficiency virus (2013) (0)
- HIV Protease with inhibitor AB-2 (2005) (0)
- Cover Picture: 1,2,3‐Triazole as a Peptide Surrogate in the Rapid Synthesis of HIV‐1 Protease Inhibitors (ChemBioChem 7/2005) (2005) (0)
- HIV-1 Protease NL4-3 3X mutant in complex with inhibitor, TL-3 (2006) (0)
- Crystal Structure of 6s-98S FIV Protease with Darunavir bound (2011) (0)
- FIV vaccine with receptor epitopes results in neutralizing antibodies but does not confer resistance to challenge (2018) (0)
- Evaluation ofFeline Immunodeficiency VirusandFelineLeukemia VirusTransmembrane Peptides forSerological Diagnosis (1992) (0)
- Proteolytic activity of feline immunodeficiency virus protease prepared by total chemical synthesis (1995) (0)
- Inhibition of nzb anti-h-2d cell mediated lympholysis (cml) by anti-gp70 antibody. Abstr. (1980) (0)
- 1 Applications of the FIV Model to Study HIV 2 Pathogenesis 3 (2018) (0)
- Selection of Drug-Resistant Feline Immunodeficiency Virus (FIV) Encoding FIV/HIV Chimeric Protease in the Presence of HIV-Specific Protease Inhibitors (2013) (0)
- Structure of HIV protease 6X mutant in complex with AB-2. (2007) (0)
- Selected soils of Madison County, Virginia: their chemical properties (1974) (0)
- Correction (1979) (0)
- HIV Protease with Scripps AB-3 Inhibitor (2005) (0)
- [Comparative characteristics of the peptide maps of the major proteins of influenza viruses type A]. (1979) (0)
- HIV protease inhibitors with small P3 residues. Broad-based Protease Inhibitors Efficacious Against FIV, SIV (1999) (0)
- SYNTHESIS OF INTRINSIC PROTEINS OF RAT LIVER ENDOMEMBRANES. (1975) (0)
- Apo Wild-type HIV Protease in the open conformation (2007) (0)
- Chemical and physical properties of soils in Northumberland and Lancaster counties, Virginia (1961) (0)
- Structure of HIV protease 6X mutant in apo form (2007) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With John Henry Elder?
John Henry Elder is affiliated with the following schools: